导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -5.95% | 727/1050 |
| 近一周 | -5.05% | 1070/1104 |
| 近一月 | 6.52% | 1/1102 |
| 近一季 | 11.88% | 72/1092 |
| 近半年 | -9.63% | 750/1070 |
| 近一年 | -18.82% | 886/1018 |
| 近两年 | 5.56% | 864/926 |
| 近三年 | -23.97% | 787/834 |
| 成立以来 | 34.21% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.05% 822/1070 |
-14.28% 1002/1101 |
- - |
- - |
| 2025 | 0.26% 926/1065 |
-2.74% 939/1014 |
3.38% 404/1038 |
5.97% 921/1050 |
-5.90% 733/1065 |
| 2024 | -25.27% 923/1011 |
-5.06% 566/960 |
-12.83% 923/983 |
-0.93% 963/991 |
-8.86% 867/1011 |
| 2023 | -8.28% 280/952 |
3.18% 434/880 |
-12.14% 809/895 |
-6.89% 421/915 |
8.67% 7/952 |
| 2022 | -17.12% 228/867 |
-5.77% 40/773 |
-4.28% 752/806 |
-6.11% 83/845 |
-2.14% 545/867 |
| 2021 | -0.78% 360/740 |
-0.05% 153/580 |
-1.88% 561/659 |
-6.47% 402/704 |
8.17% 121/740 |
| 2020 | 62.44% 179/554 |
17.42% 12/419 |
16.24% 333/466 |
13.04% 177/517 |
5.28% 434/554 |
| 2019 | 76.59% 17/410 |
51.16% 3/1146 |
2.84% 118/1228 |
3.12% 250/390 |
10.15% 157/410 |
| 2018 | -23.15% 118/349 |
- - |
-3.11% 143/990 |
-3.89% 409/1000 |
-7.93% 146/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 银华农业产业股票发起式A VS. 东吴新产业精选股票A(580008) |